Kerendia (Finerenone, BAY94-8862): clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
5
Conditions studied
0
US states with sites
2
Countries
Phase breakdown
Phase 2 1
Not applicable 1
Conditions being studied
| Condition | Trials |
|---|---|
| Type 2 Diabetes | 2 |
| Cardiovascular Autonomic Neuropathy | 1 |
| Chronic Kidney Disease | 1 |
| Diabetic Neuropathies | 1 |
| Type 2 Diabetes Mellitus | 1 |
Recruiting trials involving Kerendia (Finerenone, BAY94-8862)
- An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea
- Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN Study
Common questions
How many recruiting trials involve Kerendia (Finerenone, BAY94-8862)?
2 recruiting trials across 5 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.